Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA
Main Author: | |
---|---|
Publication Date: | 2023 |
Format: | Master thesis |
Language: | por |
Source: | Biblioteca Digital de Teses e Dissertações da UFMA |
Download full: | https://tedebc.ufma.br/jspui/handle/tede/tede/5112 |
Summary: | The virus that causes hepatitis B (HBV) is a DNA virus belonging to the Hepadnaviridae family, genus Orthohepadnavirus. It can be transmitted sexually, vertically and parenterally. Co-infection caused by the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV) occurs in considerable numbers and is related to the common transmission route of these viruses. The objective of this work is to characterize co- infection with the hepatitis B virus among people living with HIV (PLHIV) in a reference service. It was carried out from January 2022 to July 2023 in a reference hospital in the state of Maranhão for infectious-parasitic diseases and its population was PLHIV, with a clinical and serological diagnosis recorded in the medical record, aged 18 years or over, who were undergoing regular outpatient follow-up at the unit and presented results of serological markers for Hepatitis B in their medical records. Data were collected from 500 medical records based on the analysis of consultation records, carried out by the service's multidisciplinary team and compiled into an investigative form. A total of 301 records were included. 263 (87.37%) corresponded to PLHIV and 38 (12.62%) to co- infected patients (HIV and HBV). Among the co-infected patients, 21(55.26%) were between 41 and 60 years old, 35(92.11%) were male, 22(57.89%) were mixed race, 17(44.74%) were single, 11 (28.95%) had completed primary education and 38 (100%) were using antiretroviral therapy with tenofovir. Of the PLHIV, 96 individuals (36.50%) were vaccinated for hepatitis B. Of these, 37 (38.54%) received the four recommended doses of the vaccine, 82 (85.42%) had reactive Anti-HBs marker titers and 3(3 .13%) of these patients presented reactive Anti-HBs due to contact with HBV. In relation to laboratory tests, it can be seen that in the overall sample the TCD4+ cell count was less than 350mm3, with 114 (43.35%) in the PLHIV group and 19 (50%) in the group co- infected with Hepatitis B, while the HIV viral load was above 40 copies/mL, with 211 in the PLHIV group (80.23%) and 28 in the co-infected group (73.68%). Furthermore, it was identified that 38 (12.6%) people tested positive for HBsAg, 102 (38.78%) had non- reactive anti-Hbc, while 143 (54.37%) had reactive results for Anti-Hbc. HBs. As for HBeAg, 9 (23.68%) of patients co-infected with HIV and HBV had reactive results, while 21 (55.26%) had reactive results for Anti-HBe. Data regarding hepatitis B viral load indicated that the viral load was less than 2000 IU/ml in 10 (26.32%) of the patients, out of a total of 17 patients who underwent the test. Investigating the presence of the hepatitis B virus, by carrying out specific tests, and evaluating the vaccination status for HBV in PLHIV can play a crucial role in improving the prognosis in this population. |
id |
UFMA_f00c8aa5250464463cbd0230e6290ac5 |
---|---|
oai_identifier_str |
oai:tede2:tede/5112 |
network_acronym_str |
UFMA |
network_name_str |
Biblioteca Digital de Teses e Dissertações da UFMA |
repository_id_str |
2131 |
spelling |
AZEVEDO, Conceição de Maria Pedrozo e Silva dehttp://lattes.cnpq.br/1702212486285798AZEVEDO, Conceição de Maria Pedrozo e Silva dehttp://lattes.cnpq.br/1702212486285798PESSOA, Debora Luana Ribeirohttp://lattes.cnpq.br/2537676284852975SIMÕES, Vanda Maria Ferreirahttp://lattes.cnpq.br/4024829764707677SANTOS, Daniel Wagner de Castro Limahttp://lattes.cnpq.br/9535568373737991http://lattes.cnpq.br/4837728641665887SOUZA, Dayse Azevedo Coelho de2024-01-31T12:36:01Z2023-11-29SOUZA, Dayse Azevedo Coelho de. Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA. 2023. 66 f. Dissertação (Programa de Pós-Graduação em Ciências da Saúde/CCBS) - Universidade Federal do Maranhão, São Luís, 2023.https://tedebc.ufma.br/jspui/handle/tede/tede/5112The virus that causes hepatitis B (HBV) is a DNA virus belonging to the Hepadnaviridae family, genus Orthohepadnavirus. It can be transmitted sexually, vertically and parenterally. Co-infection caused by the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV) occurs in considerable numbers and is related to the common transmission route of these viruses. The objective of this work is to characterize co- infection with the hepatitis B virus among people living with HIV (PLHIV) in a reference service. It was carried out from January 2022 to July 2023 in a reference hospital in the state of Maranhão for infectious-parasitic diseases and its population was PLHIV, with a clinical and serological diagnosis recorded in the medical record, aged 18 years or over, who were undergoing regular outpatient follow-up at the unit and presented results of serological markers for Hepatitis B in their medical records. Data were collected from 500 medical records based on the analysis of consultation records, carried out by the service's multidisciplinary team and compiled into an investigative form. A total of 301 records were included. 263 (87.37%) corresponded to PLHIV and 38 (12.62%) to co- infected patients (HIV and HBV). Among the co-infected patients, 21(55.26%) were between 41 and 60 years old, 35(92.11%) were male, 22(57.89%) were mixed race, 17(44.74%) were single, 11 (28.95%) had completed primary education and 38 (100%) were using antiretroviral therapy with tenofovir. Of the PLHIV, 96 individuals (36.50%) were vaccinated for hepatitis B. Of these, 37 (38.54%) received the four recommended doses of the vaccine, 82 (85.42%) had reactive Anti-HBs marker titers and 3(3 .13%) of these patients presented reactive Anti-HBs due to contact with HBV. In relation to laboratory tests, it can be seen that in the overall sample the TCD4+ cell count was less than 350mm3, with 114 (43.35%) in the PLHIV group and 19 (50%) in the group co- infected with Hepatitis B, while the HIV viral load was above 40 copies/mL, with 211 in the PLHIV group (80.23%) and 28 in the co-infected group (73.68%). Furthermore, it was identified that 38 (12.6%) people tested positive for HBsAg, 102 (38.78%) had non- reactive anti-Hbc, while 143 (54.37%) had reactive results for Anti-Hbc. HBs. As for HBeAg, 9 (23.68%) of patients co-infected with HIV and HBV had reactive results, while 21 (55.26%) had reactive results for Anti-HBe. Data regarding hepatitis B viral load indicated that the viral load was less than 2000 IU/ml in 10 (26.32%) of the patients, out of a total of 17 patients who underwent the test. Investigating the presence of the hepatitis B virus, by carrying out specific tests, and evaluating the vaccination status for HBV in PLHIV can play a crucial role in improving the prognosis in this population.O vírus causador da hepatite B (VHB) é um vírus de DNA que pertencente à família Hepadnaviridae, gênero Orthohepadnavírus. Sua transmissão pode ser por via sexual, vertical e parenteral. A coinfecção causada pelo vírus da imunodeficiência humana (HIV) e o vírus da hepatite B (VHB) ocorre em número considerável e está relacionada a via de transmissão comum a estes vírus. O objetivo deste trabalho é caracterizar a coinfecção pelo vírus da hepatite B entre as pessoas que vivem com HIV (PVHIV) em um serviço de referência. Foi realizado no período de janeiro de 2022 a julho de 2023 em um hospital de referência do estado do Maranhão em doenças infecto-parasitárias e teve como população PVHIV, com diagnóstico clínico e sorológico registrado em prontuário, idade igual ou superior a 18 anos, que faziam acompanhamento ambulatorial regular na unidade e que apresentaram resultados de marcadores sorológicos para Hepatite B, no prontuário. Foram coletados dados de 500 prontuários a partir da análise dos registros de consultas, realizadas pela equipe multiprofissional do serviço e compiladas para uma ficha investigatória. Um total 301 fichas foram incluídas.263(87,37%) correspondiam a PVHIV e 38(12,62%) a pacientes coinfectados (HIV e VHB). Entre os pacientes coinfectados 21(55,26%) tinham entre 41 a 60 anos, 35(92,11%) eram do sexo masculino, 22(57,89%) eram pardos,17(44,74%) eram solteiros, 11(28,95%) tinham ensino fundamental completo e 38(100%) faziam uso da terapia antirretroviral com tenofovir. Das PVHIV 96 indivíduos (36,50%) eram vacinados para hepatite B. Destes 37 (38,54%) receberam as quatro doses recomendadas da vacina, 82 (85,42%) apresentaram títulos marcadores reagentes Anti-HBs e 3(3,13%) desses pacientes apresentaram Anti -HBs reagente devido ao contato com o VHB. Em relação aos exames laboratoriais pode-se observar que na amostra global a contagem de células TCD4+ foi inferior a 350mm3, sendo 114 (43,35%) no grupo PVHIV e 19 (50%) no grupo de coinfectados com Hepatite B, enquanto a carga viral do HIV estava acima de 40 cópias/mL, sendo no grupo PVHIV 211 (80,23%) e no grupo de coinfectados 28 (73,68%). Além disso, identificou-se que 38 (12,6%) pessoas testaram positivo para o HBsAg, 102 (38,78%) apresentaram anti- Hbc não reagente, enquanto 143 (54,37%) apresentaram resultados reagentes para o Anti- HBs. Quanto ao HBeAg, 9 (23,68%) dos pacientes coinfectados com HIV e VHB tiveram resultados reagentes, enquanto 21 (55,26%) apresentaram resultados reagentes para o Anti-HBe. Os dados relativos à carga viral da hepatite B indicaram que a carga viral foi inferior a 2000 UI/ml em 10 (26,32%) dos pacientes, de um total de 17 pacientes que realizaram o exame. A investigação da presença do vírus da hepatite B, através da realização de testes específicos, e avaliação do estado vacinal em relação ao VHB em PVHIV podem desempenhar um papel crucial na melhoria do prognóstico nesta população.Submitted by Jonathan Sousa de Almeida (jonathan.sousa@ufma.br) on 2024-01-31T12:36:01Z No. of bitstreams: 1 DAYSEAZEVEDOCOELHODESOUZA.pdf: 1127485 bytes, checksum: d0d7101e9740c636253abe2f095f49bc (MD5)Made available in DSpace on 2024-01-31T12:36:01Z (GMT). No. of bitstreams: 1 DAYSEAZEVEDOCOELHODESOUZA.pdf: 1127485 bytes, checksum: d0d7101e9740c636253abe2f095f49bc (MD5) Previous issue date: 2023-11-29application/pdfporUniversidade Federal do MaranhãoPROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE/CCBSUFMABrasilDEPARTAMENTO DE MEDICINA I/CCBSHepatite B;Pessoas que vivem com HIV (PVHIV);coinfectado.Hepatitis B;People living with HIV (PLHIV);CoinfectedDoenças InfecciosasCiências da SaúdeCaracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MACharacterization of HIV and hepatitis B co-infection in the population of a referral hospital in São Luís - MAinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFMAinstname:Universidade Federal do Maranhão (UFMA)instacron:UFMAORIGINALDAYSEAZEVEDOCOELHODESOUZA.pdfDAYSEAZEVEDOCOELHODESOUZA.pdfapplication/pdf1127485http://tedebc.ufma.br:8080/bitstream/tede/5112/2/DAYSEAZEVEDOCOELHODESOUZA.pdfd0d7101e9740c636253abe2f095f49bcMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82255http://tedebc.ufma.br:8080/bitstream/tede/5112/1/license.txt97eeade1fce43278e63fe063657f8083MD51tede/51122024-01-31 09:36:01.057oai:tede2: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Biblioteca Digital de Teses e Dissertaçõeshttps://tedebc.ufma.br/jspui/PUBhttp://tedebc.ufma.br:8080/oai/requestrepositorio@ufma.br||repositorio@ufma.bropendoar:21312024-01-31T12:36:01Biblioteca Digital de Teses e Dissertações da UFMA - Universidade Federal do Maranhão (UFMA)false |
dc.title.por.fl_str_mv |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
dc.title.alternative.eng.fl_str_mv |
Characterization of HIV and hepatitis B co-infection in the population of a referral hospital in São Luís - MA |
title |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
spellingShingle |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA SOUZA, Dayse Azevedo Coelho de Hepatite B; Pessoas que vivem com HIV (PVHIV); coinfectado. Hepatitis B; People living with HIV (PLHIV); Coinfected Doenças Infecciosas Ciências da Saúde |
title_short |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
title_full |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
title_fullStr |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
title_full_unstemmed |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
title_sort |
Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA |
author |
SOUZA, Dayse Azevedo Coelho de |
author_facet |
SOUZA, Dayse Azevedo Coelho de |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
AZEVEDO, Conceição de Maria Pedrozo e Silva de |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/1702212486285798 |
dc.contributor.referee1.fl_str_mv |
AZEVEDO, Conceição de Maria Pedrozo e Silva de |
dc.contributor.referee1Lattes.fl_str_mv |
http://lattes.cnpq.br/1702212486285798 |
dc.contributor.referee2.fl_str_mv |
PESSOA, Debora Luana Ribeiro |
dc.contributor.referee2Lattes.fl_str_mv |
http://lattes.cnpq.br/2537676284852975 |
dc.contributor.referee3.fl_str_mv |
SIMÕES, Vanda Maria Ferreira |
dc.contributor.referee3Lattes.fl_str_mv |
http://lattes.cnpq.br/4024829764707677 |
dc.contributor.referee4.fl_str_mv |
SANTOS, Daniel Wagner de Castro Lima |
dc.contributor.referee4Lattes.fl_str_mv |
http://lattes.cnpq.br/9535568373737991 |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/4837728641665887 |
dc.contributor.author.fl_str_mv |
SOUZA, Dayse Azevedo Coelho de |
contributor_str_mv |
AZEVEDO, Conceição de Maria Pedrozo e Silva de AZEVEDO, Conceição de Maria Pedrozo e Silva de PESSOA, Debora Luana Ribeiro SIMÕES, Vanda Maria Ferreira SANTOS, Daniel Wagner de Castro Lima |
dc.subject.por.fl_str_mv |
Hepatite B; Pessoas que vivem com HIV (PVHIV); coinfectado. |
topic |
Hepatite B; Pessoas que vivem com HIV (PVHIV); coinfectado. Hepatitis B; People living with HIV (PLHIV); Coinfected Doenças Infecciosas Ciências da Saúde |
dc.subject.eng.fl_str_mv |
Hepatitis B; People living with HIV (PLHIV); Coinfected |
dc.subject.cnpq.fl_str_mv |
Doenças Infecciosas Ciências da Saúde |
description |
The virus that causes hepatitis B (HBV) is a DNA virus belonging to the Hepadnaviridae family, genus Orthohepadnavirus. It can be transmitted sexually, vertically and parenterally. Co-infection caused by the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV) occurs in considerable numbers and is related to the common transmission route of these viruses. The objective of this work is to characterize co- infection with the hepatitis B virus among people living with HIV (PLHIV) in a reference service. It was carried out from January 2022 to July 2023 in a reference hospital in the state of Maranhão for infectious-parasitic diseases and its population was PLHIV, with a clinical and serological diagnosis recorded in the medical record, aged 18 years or over, who were undergoing regular outpatient follow-up at the unit and presented results of serological markers for Hepatitis B in their medical records. Data were collected from 500 medical records based on the analysis of consultation records, carried out by the service's multidisciplinary team and compiled into an investigative form. A total of 301 records were included. 263 (87.37%) corresponded to PLHIV and 38 (12.62%) to co- infected patients (HIV and HBV). Among the co-infected patients, 21(55.26%) were between 41 and 60 years old, 35(92.11%) were male, 22(57.89%) were mixed race, 17(44.74%) were single, 11 (28.95%) had completed primary education and 38 (100%) were using antiretroviral therapy with tenofovir. Of the PLHIV, 96 individuals (36.50%) were vaccinated for hepatitis B. Of these, 37 (38.54%) received the four recommended doses of the vaccine, 82 (85.42%) had reactive Anti-HBs marker titers and 3(3 .13%) of these patients presented reactive Anti-HBs due to contact with HBV. In relation to laboratory tests, it can be seen that in the overall sample the TCD4+ cell count was less than 350mm3, with 114 (43.35%) in the PLHIV group and 19 (50%) in the group co- infected with Hepatitis B, while the HIV viral load was above 40 copies/mL, with 211 in the PLHIV group (80.23%) and 28 in the co-infected group (73.68%). Furthermore, it was identified that 38 (12.6%) people tested positive for HBsAg, 102 (38.78%) had non- reactive anti-Hbc, while 143 (54.37%) had reactive results for Anti-Hbc. HBs. As for HBeAg, 9 (23.68%) of patients co-infected with HIV and HBV had reactive results, while 21 (55.26%) had reactive results for Anti-HBe. Data regarding hepatitis B viral load indicated that the viral load was less than 2000 IU/ml in 10 (26.32%) of the patients, out of a total of 17 patients who underwent the test. Investigating the presence of the hepatitis B virus, by carrying out specific tests, and evaluating the vaccination status for HBV in PLHIV can play a crucial role in improving the prognosis in this population. |
publishDate |
2023 |
dc.date.issued.fl_str_mv |
2023-11-29 |
dc.date.accessioned.fl_str_mv |
2024-01-31T12:36:01Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SOUZA, Dayse Azevedo Coelho de. Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA. 2023. 66 f. Dissertação (Programa de Pós-Graduação em Ciências da Saúde/CCBS) - Universidade Federal do Maranhão, São Luís, 2023. |
dc.identifier.uri.fl_str_mv |
https://tedebc.ufma.br/jspui/handle/tede/tede/5112 |
identifier_str_mv |
SOUZA, Dayse Azevedo Coelho de. Caracterização da coinfecção HIV e hepatite B na população de um hospital de referência em São Luís - MA. 2023. 66 f. Dissertação (Programa de Pós-Graduação em Ciências da Saúde/CCBS) - Universidade Federal do Maranhão, São Luís, 2023. |
url |
https://tedebc.ufma.br/jspui/handle/tede/tede/5112 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal do Maranhão |
dc.publisher.program.fl_str_mv |
PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE/CCBS |
dc.publisher.initials.fl_str_mv |
UFMA |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
DEPARTAMENTO DE MEDICINA I/CCBS |
publisher.none.fl_str_mv |
Universidade Federal do Maranhão |
dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Teses e Dissertações da UFMA instname:Universidade Federal do Maranhão (UFMA) instacron:UFMA |
instname_str |
Universidade Federal do Maranhão (UFMA) |
instacron_str |
UFMA |
institution |
UFMA |
reponame_str |
Biblioteca Digital de Teses e Dissertações da UFMA |
collection |
Biblioteca Digital de Teses e Dissertações da UFMA |
bitstream.url.fl_str_mv |
http://tedebc.ufma.br:8080/bitstream/tede/5112/2/DAYSEAZEVEDOCOELHODESOUZA.pdf http://tedebc.ufma.br:8080/bitstream/tede/5112/1/license.txt |
bitstream.checksum.fl_str_mv |
d0d7101e9740c636253abe2f095f49bc 97eeade1fce43278e63fe063657f8083 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Biblioteca Digital de Teses e Dissertações da UFMA - Universidade Federal do Maranhão (UFMA) |
repository.mail.fl_str_mv |
repositorio@ufma.br||repositorio@ufma.br |
_version_ |
1797048352502710272 |